A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency

In this study, we sought to evaluate the inter-batch consistency and safety of the CTN-1 V human rabies vaccine (Vero cells). A total of 594 healthy participants aged 10–60 years were enrolled from Mianzhu, Sichuan Province, and randomized into three batch groups to receive vaccination via the Essen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lei, Liu, Jingjing, Li, Jia, Liu, Xuecheng, Zhang, Jingwu, Nie, Fei, Chen, Jianmin, Chai, Jing, Lv, Jinchao, Wang, Minghui, Yu, Jiajie, Wu, Wenjie, Li, Yuhua, Zhang, Yuhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Licensed Vaccines – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746391/
https://www.ncbi.nlm.nih.gov/pubmed/36409064
http://dx.doi.org/10.1080/21645515.2022.2138049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746391/
https://www.ncbi.nlm.nih.gov/pubmed/36409064
http://dx.doi.org/10.1080/21645515.2022.2138049

Ejemplares similares